02/09/2020 (Agence Europe) – The European Medicines Agency (EMA) is currently examining the possibility of authorising the use of Dexamethasone Taw to treat adult inpatients with Covid-19, the Agency announced in a press release on Wednesday 2 September. Drugs bases on Dexamethasone Taw have been approved for several decades to treat various infections due to their anti-inflammatory properties. The British Recovery trial had highlighted the good results of this drug in July 2020. The...